Abstract: Background: Although cannabinoid consumption represents a current social and health problem, especially in a historical context characterized by an open orientation for recreational and therapeutic purposes, risks regarding the neurotoxicity of such substances are frequently overlooked. Objective: The present systematic review aims to summarize the available evidence regarding the mechanism of cannabinoids-induced brain damage as a substrate of neurological, psychiatric, and behavioral effects. Another objective is to provide support for future investigations and legislative choices. Methods: The systematic literature search through PubMed and Scopus and a critical appraisal of the collected studies were conducted. Search terms were “(("Cannabinoids" OR "THC" OR "CBD") AND "Brain” AND ("Damage" OR "Toxicity"))” in the title and abstracts. Studies were included examining toxic effects on the brain potentially induced by cannabinoids on human subjects. Results: At the end of the literature selection process, 30 papers were considered for the present review. The consumption of cannabinoids is associated with the development of psychiatric, neuro- cognitive, neurological disorders and, in some cases of acute consumption, even death. In this sense, the greatest risks have been related to the consumption of high-potency synthetic cannabinoids, al- though the consumption of phytocannabinoids is not devoid of risks. Conclusion: The research carried out has allowed to highlight some critical points to focus on, such as the need to reinforce the toxic-epidemiologic monitor of new substances market and the impor- tance of information for both medical personnel and general population, with particular attention to the mostly involved age groups.

Cannabinoids and brain damage. A systematic review on a frequently overlooked issue / Scopetti, M.; Morena, D.; Manetti, F.; Santurro, A.; Di Fazio, N.; D?errico, S.; Padovano, M.; Frati, P.; Fineschi, V.. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1873-4316. - 24:6(2023), pp. 741-757. [10.2174/1389201023666220614145535]

Cannabinoids and brain damage. A systematic review on a frequently overlooked issue

Scopetti, M.;Morena, D.;Manetti, F.;Santurro, A.;Di Fazio, N.
;
Padovano, M.;Frati, P.;Fineschi, V.
2023

Abstract

Abstract: Background: Although cannabinoid consumption represents a current social and health problem, especially in a historical context characterized by an open orientation for recreational and therapeutic purposes, risks regarding the neurotoxicity of such substances are frequently overlooked. Objective: The present systematic review aims to summarize the available evidence regarding the mechanism of cannabinoids-induced brain damage as a substrate of neurological, psychiatric, and behavioral effects. Another objective is to provide support for future investigations and legislative choices. Methods: The systematic literature search through PubMed and Scopus and a critical appraisal of the collected studies were conducted. Search terms were “(("Cannabinoids" OR "THC" OR "CBD") AND "Brain” AND ("Damage" OR "Toxicity"))” in the title and abstracts. Studies were included examining toxic effects on the brain potentially induced by cannabinoids on human subjects. Results: At the end of the literature selection process, 30 papers were considered for the present review. The consumption of cannabinoids is associated with the development of psychiatric, neuro- cognitive, neurological disorders and, in some cases of acute consumption, even death. In this sense, the greatest risks have been related to the consumption of high-potency synthetic cannabinoids, al- though the consumption of phytocannabinoids is not devoid of risks. Conclusion: The research carried out has allowed to highlight some critical points to focus on, such as the need to reinforce the toxic-epidemiologic monitor of new substances market and the impor- tance of information for both medical personnel and general population, with particular attention to the mostly involved age groups.
2023
toxicology; cannabinoids; cannabis; brain damage; toxicity; thc; cbd
01 Pubblicazione su rivista::01a Articolo in rivista
Cannabinoids and brain damage. A systematic review on a frequently overlooked issue / Scopetti, M.; Morena, D.; Manetti, F.; Santurro, A.; Di Fazio, N.; D?errico, S.; Padovano, M.; Frati, P.; Fineschi, V.. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1873-4316. - 24:6(2023), pp. 741-757. [10.2174/1389201023666220614145535]
File allegati a questo prodotto
File Dimensione Formato  
Scopetti_Cannabinoids_2023.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 922.39 kB
Formato Adobe PDF
922.39 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1699067
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact